REGENXBIO Inc.

NASDAQ: RGNX · Real-Time Price · USD
8.82
-0.24 (-2.65%)
At close: Aug 15, 2025, 3:59 PM
8.88
0.62%
After-hours: Aug 15, 2025, 05:44 PM EDT

REGENXBIO Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-227.1M -263.49M -280.32M 127.84M
Depreciation & Amortization
16.21M 17.32M 12.91M 9.56M
Stock-Based Compensation
38.46M 40.27M 40.79M 38.81M
Other Working Capital
-3.88M -12.03M -9.63M -899K
Other Non-Cash Items
-6.23M -1.61M 5.16M 4.36M
Deferred Income Tax
n/a n/a n/a -1.92M
Change in Working Capital
5.53M -10.89M 13.98M 40.22M
Operating Cash Flow
-173.13M -218.41M -207.49M 218.88M
Capital Expenditures
-2.44M -9.96M -30.72M -84.17M
Cash Acquisitions
n/a n/a n/a -4.99M
Purchase of Investments
-190.14M -86.56M -184.88M -498.14M
Sales Maturities Of Investments
290.24M 287.47M 203.67M 175.68M
Other Investing Acitivies
5.78M n/a 0.00 4.99M
Investing Cash Flow
103.45M 190.94M -11.93M -406.64M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
1.19M n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-39.58M -41.67M -30.58M -22.96M
Financial Cash Flow
92.68M -34.97M -28.84M 195.25M
Net Cash Flow
23M -62.43M -248.26M 7.48M
Free Cash Flow
-175.56M -228.37M -238.21M 134.7M